Ferumoxytol-enhanced cardiovascular magnetic resonance detection of early stage acute myocarditis

Abstract Background The diagnostic utility of cardiovascular magnetic resonance (CMR) is limited during the early stages of myocarditis. This study examined whether ferumoxytol-enhanced CMR (FE-CMR) could detect an earlier stage of acute myocarditis compared to gadolinium-enhanced CMR. Methods Lewis...

Full description

Bibliographic Details
Published in:	Journal of Cardiovascular Magnetic Resonance
Main Authors:	Yuko Tada, Atsushi Tachibana, Shahriar Heidary, Phillip C. Yang, Michael V. McConnell, Rajesh Dash
Format:	Article
Language:	English
Published:	Elsevier 2019-12-01
Subjects:	Ferumoxytol CMR MRI Myocarditis T2* map
Online Access:	https://doi.org/10.1186/s12968-019-0587-7

Similar Items

Blood volume measurement using cardiovascular magnetic resonance and ferumoxytol: preclinical validation
by: Rajiv Ramasawmy, et al.
Published: (2018-09-01)

Ferumoxytol-enhanced magnetic resonance angiography for endovascular aortic repair surveillance in a patient after renal transplant
by: Richard Longfei Li, MD, et al.
Published: (2025-10-01)

Exploring the limits of scan time reduction for ferumoxytol-enhanced whole-heart angiography in congenital heart disease patients
by: Ludovica Romanin, et al.
Published: (2025-01-01)

Impact of ferumoxytol vs gadolinium on 4D flow cardiovascular magnetic resonance measurements in small children with congenital heart disease
by: Sarah E. Kollar, et al.
Published: (2022-11-01)

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging
by: Kim-Lien Nguyen, et al.
Published: (2017-12-01)

Cardiovascular magnetic resonance imaging and clinical follow-up in patients with clinically suspected myocarditis after COVID-19 vaccination
by: Norain Talib, et al.
Published: (2024-01-01)

MRI Detection and Therapeutic Enhancement of Ferumoxytol Internalization in Glioblastoma Cells
by: Michael S. Petronek, et al.
Published: (2024-01-01)

Mapping vascular network architecture in primate brain using ferumoxytol-weighted laminar MRI
by: Joonas A Autio, et al.
Published: (2025-06-01)

Cardiovascular Magnetic Resonance Imaging Pattern in <i>Campylobacter jejuni</i>-related Myocarditis
by: Nabil Belfeki, et al.
Published: (2022-01-01)

Polyelectrolyte Coating of Ferumoxytol Differentially Impacts the Labeling of Inflammatory and Steady-State Dendritic Cell Subtypes
by: Nehar Celikkin, et al.
Published: (2022-12-01)

High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion
by: Puja Shahrouki, et al.
Published: (2019-03-01)

Diffuse Active Myocarditis in a Teenager with Duchenne Muscular Dystrophy - a case report
by: Mohammad Mahdavi, et al.
Published: (2025-05-01)

Comprehensive Cardiovascular Magnetic Resonance‐Derived Myocardial Strain Analysis Provides Independent Prognostic Value in Acute Myocarditis
by: Jacqueline L. Vos, et al.
Published: (2022-10-01)

Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study
by: Julia Treiber, et al.
Published: (2023-02-01)

Manifold-based denoising for Ferumoxytol-enhanced 3D cardiac cine MRI
by: Anna Andrews, et al.
Published: (2024-02-01)

Post-RNA (mRNA) Vaccination Myocarditis: CMR Features
by: Karuna M. Das, et al.
Published: (2022-04-01)

Acute myocarditis morphologically mimicking reverse takotsubo cardiomyopathy
by: Sherief Sulaiman, et al.
Published: (2017-01-01)

Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis
by: Christoph Gräni, et al.
Published: (2019-02-01)

Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis
by: Jieli Tong, et al.
Published: (2024-08-01)

Mesalazine-induced myocarditis: a case report
by: Shiva T. Radhakrishnan, et al.
Published: (2018-02-01)

Dual-enzyme activated theranostic nanoparticles for image-guided glioblastoma therapy
by: Zahra Shokri Varniab, et al.
Published: (2025-04-01)

Prognostic relevance of demographic factors in cardiac magnetic resonance-proven acute myocarditis: A cohort study
by: Antonio Cannata, et al.
Published: (2022-10-01)

A Blind Spot in Imaging: Immune Checkpoint Inhibitor-Induced Myocarditis with Negative Cardiac MRI
by: Lubna Alnatour, et al.
Published: (2025-05-01)

Utility of a New Bolus-injectable Nanoparticle for Clinical Cancer Staging
by: Mukesh Harisinghani, et al.
Published: (2007-12-01)

1–2 T static magnetic field combined with Ferumoxytol prevent unloading-induced bone loss by regulating iron metabolism in osteoclastogenesis
by: Gejing Zhang, et al.
Published: (2023-01-01)

Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: Rationale & design of the ARCHER trial
by: Dennis M. McNamara, et al.
Published: (2024-10-01)

CMR Manifestations, Influencing Factors and Molecular Mechanism of Myocarditis Induced by COVID-19 Mrna Vaccine
by: Chao-Fei Ba, et al.
Published: (2022-10-01)

Four challenging cases of eosinophilic endocarditis or myocarditis with literature review
by: Ping Chen, et al.
Published: (2025-05-01)

How Reproducible Is Feraheme<sup>®</sup> (Ferumoxytol Injection)? Comparison of Size, Zeta Potential, and Complement Activation of Different Batches over 15 Years
by: Utibeabasi Ettah, et al.
Published: (2024-09-01)

The Relationship Between Electrocardiographic Findings and Cardiac Magnetic Resonance Results in Patients with Acute Myocarditis: A Retrospective Analysis
by: Michaela Kyriakou, et al.
Published: (2025-08-01)

Systematic use of cardiac magnetic resonance imaging in MINOCA led to a five-fold increase in the detection rate of myocarditis: a retrospective study
by: Bettina Heidecker, et al.
Published: (2019-07-01)

Ferumoxytol-Enhanced Cardiac Magnetic Resonance Angiography and 4D Flow: Safety and Utility in Pediatric and Adult Congenital Heart Disease
by: Pierangelo Renella, et al.
Published: (2022-11-01)

Contemporary sequential segmental approach to congenital heart disease using four-dimensional magnetic resonance imaging with ferumoxytol: an illustrated editorial
by: Shi-Joon Yoo, et al.
Published: (2023-07-01)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
by: Adkinson NF, et al.
Published: (2017-09-01)

A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis
by: Adedayo Adeboye, et al.
Published: (2022-02-01)

Comparison of Cardiac Activated Fibroblast Imaging and Magnetic Resonance Imaging in Patients with COVID-19-Related Myocarditis
by: Yao Su, et al.
Published: (2024-05-01)

Characterizing extravascular lung water—A dual-contrast agent extracellular volume approach by cardiovascular magnetic resonance
by: Felicia Seemann, et al.
Published: (2025-01-01)

Eosinophilic myocarditis: Magnetic resonance imaging -based study of a dramatic response to steroids
by: Aayush Kumar Singal, et al.
Published: (2020-08-01)

Cardiovascular Magnetic Resonance in Myocarditis
by: Christian L. Polte, et al.
Published: (2022-02-01)

Role of Cardiac Magnetic Resonance Imaging in Hypocalcemia-Induced Dilated Cardiomyopathy in Pediatric Population
by: Ankit Garg, et al.
Published: (2021-10-01)